Vienna 2019: The International Drug Control System under Stress

 

deien12.jpg

Drugs, International Challenges n° 12, OFDT, 9 p.
November 2019

The international landscape is becoming more complex and polarised on legislative drug issues, as the last Commission on Narcotic Drugs (CND) has shown. The 62nd regular session of the CND was held from 18 to 23 March 2019 in Vienna. Throughout more than a week of debates, the Austrian capital welcomed nearly 2 400 participants, including several ministers and heads of government, representing a wide range of invested parties (Member States, UN agencies, civil society organisations, the scientific world, etc.). In addition to this annual session, a special "ministerial segment" was added on 14 and 15 March to take stock of the efforts made over the last ten years to "address and combat the world drug problem".

This issue of Drugs, international challenges breaks down these 10 days of debates, offering a detailed analysis of the issues and developments that will shape the next years of international drug policy.

 

 

Authors: Deborah Alimi, Jennifer Hasselgard-Rowe

Download the PDF file (1 062 Ko)

 

 

 

 

 

 

 

Drugs in Europe


2021 EMCDDA European Drug Report

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2021

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.